Your browser doesn't support javascript.
loading
Fabry-Stroke Italian Registry (FSIR): a nationwide, prospective, observational study about incidence and characteristics of Fabry-related stroke in young-adults. Presentation of the study protocol.
Romani, Ilaria; Nencini, Patrizia; Sarti, Cristina; Pracucci, Giovanni; Zedde, Marialuisa; Nucera, Antonia; Cianci, Vittoria; Moller, Jessica; Toni, Danilo; Orsucci, Daniele; Casella, Carmela; Pinto, Vincenza; Palumbo, Pasquale; Barbarini, Leonardo; Bella, Rita; Ragno, Michele; Scoditti, Umberto; Mezzapesa, Domenico Maria; Tassi, Rossana; Diomedi, Marina; Cavallini, Anna; Volpi, Gino; Chiti, Alberto; Bigliardi, Guido; Sacco, Simona; Linoli, Giovanni; Ricci, Stefano; Giordano, Antonello; Bonetti, Bruno; Rasura, Maurizia; Cecconi, Emanuela; Princiotta Cariddi, Lucia; Currò Dossi, Roberto; Melis, Marta; Consoli, Domenico; Guidetti, Donata; Biagini, Silvia; Accavone, Donatella; Inzitari, Domenico.
Afiliación
  • Romani I; Department of Neurosciences, Psychology, Pharmacology, and Child Health (NEUROFARBA), University of Florence, Florence, Italy. ilaria.romani@unifi.it.
  • Nencini P; Stroke Unit, Careggi University Hospital, Firenze, Italy.
  • Sarti C; Department of Neurosciences, Psychology, Pharmacology, and Child Health (NEUROFARBA), University of Florence, Florence, Italy.
  • Pracucci G; Department of Neurosciences, Psychology, Pharmacology, and Child Health (NEUROFARBA), University of Florence, Florence, Italy.
  • Zedde M; Neurology, S. Maria Nuova Hospital, Reggio Emilia, Italy.
  • Nucera A; Neurovascular Treatment Unit, Spaziani Hospital, Frosinone, Italy.
  • Cianci V; Neurology, Bianchi-Melacrino-Morelli Hospital, Reggio Calabria, Italy.
  • Moller J; Neurology-Stroke Unit, Brotzu Hospital, Cagliari, Italy.
  • Toni D; Emergency Department Stroke Unit, Umberto I Polyclinic Hospital, Sapienza University of Rome, Rome, Italy.
  • Orsucci D; Neurology, Lucca Hospital, Lucca, Italy.
  • Casella C; Stroke Unit, Department of Clinical and Experimental Medicine, AOU Policlinico G. Martino, University of Messina, Messina, Italy.
  • Pinto V; Neurology and Stroke Unit, Di Summa - Perrino Hospital, Brindisi, Italy.
  • Palumbo P; Neurology, Neurophysiopathology, and Stroke Unit, Santo Stefano Hospital, Prato, Italy.
  • Barbarini L; Stroke Unit, Fazzi Hospital, Lecce, Italy.
  • Bella R; Acute Cerebrovascular Diseases Unit, Vittorio Emanuele University Hospital, Catania, Italy.
  • Ragno M; Division of Neurology, C. e G. Mazzoni Hospital and Madonna del Soccorso Hospital, Ascoli Piceno, Italy.
  • Scoditti U; Neurology - Stroke Care Program, Parma University Hospital, Parma, Italy.
  • Mezzapesa DM; University Neurology, Bari Polyclinic Hospital, Bari, Italy.
  • Tassi R; Neurosonology and Stroke Unit, Siena University Hospital, Siena, Italy.
  • Diomedi M; Neurovascular Treatment Unit, Tor Vergata Polyclinic Hospital, Rome, Italy.
  • Cavallini A; Stroke Unit, C. Mondino Foundation, Pavia, Italy.
  • Volpi G; Neurology, San Iacopo Hospital, Pistoia, Italy.
  • Chiti A; Neurology, Apuane Hospital, Massa e Carrara, Italy.
  • Bigliardi G; Stroke Unit, Sant'Agostino Estense New Hospital, Modena, Italy.
  • Sacco S; Neurology and Stroke Unit, SS Filippo e Nicola Hospital , Avezzano, Italy.
  • Linoli G; Neurology, San Donato Hospital, Arezzo, Italy.
  • Ricci S; Stroke Center - Neurology, Città Di Castello Hospital and Gubbio-Gualdo Tadino Hospital, Città di Castello, Italy.
  • Giordano A; Neurology, Guzzardi Hospital, Ragusa, Italy.
  • Bonetti B; Stroke Unit, Verona University Hospital, Verona, Italy.
  • Rasura M; Neurology, Sant'Andrea Hospital, Rome, Italy.
  • Cecconi E; Neurovascular Treatment Unit, Belcolle Hospital, Viterbo, Italy.
  • Princiotta Cariddi L; Neurology, Circolo University Hospital, Varese, Italy.
  • Currò Dossi R; Stroke Unit, Bolzano Hospital, Bolzano, Italy.
  • Melis M; Neurology, Monserrato University Hospital, Cagliari, Italy.
  • Consoli D; Neurology, Jazzolino Hospital, Vibo Valentia, Italy.
  • Guidetti D; Neurology, Da Saliceto Hospital, Piacenza, Italy.
  • Biagini S; Department of Neurosciences, Psychology, Pharmacology, and Child Health (NEUROFARBA), University of Florence, Florence, Italy.
  • Accavone D; Department of Neurosciences, Psychology, Pharmacology, and Child Health (NEUROFARBA), University of Florence, Florence, Italy.
  • Inzitari D; Department of Neurosciences, Psychology, Pharmacology, and Child Health (NEUROFARBA), University of Florence, Florence, Italy.
Neurol Sci ; 43(4): 2433-2439, 2022 Apr.
Article en En | MEDLINE | ID: mdl-34609660
ABSTRACT

BACKGROUND:

TIA and stroke, both ischemic and hemorrhagic, may complicate Fabry disease at young-adult age and be the first manifestation that comes to the clinician's attention. No definite indications have yet been elaborated to guide neurologists in Fabry disease diagnostics. In current practice, it is usually sought in case of cryptogenic strokes (while Fabry-related strokes can also occur by classical pathogenic mechanisms) or through screening programs in young cerebrovascular populations. Data on recurrence and secondary prevention of Fabry's stroke are scanty.

METHODS:

The study had a prospective observational design involving 33 Italian neurological Stroke Units. Considering the incidence of TIA/stroke in the European population aged < 60 years and the frequency of Fabry disease in this category (as foreseen by a pilot study held at the Careggi University-Hospital, Florence), we planned to screen for Fabry disease a total of 1740 < 60-year-old individuals hospitalized for TIA, ischemic, or hemorrhagic stroke. We investigated TIA and stroke pathogenesis through internationally validated scales and we gathered information on possible early signs of Fabry disease among all cerebrovascular patients. Every patient was tested for Fabry disease through dried blood spot analysis. Patients who received Fabry disease diagnosis underwent a 12-month follow-up to monitor stroke recurrence and multi-system progression after the cerebrovascular event.

DISCUSSION:

The potential implications of this study are as follows (i) to add information about the yield of systematic screening for Fabry disease in a prospective large cohort of acute cerebrovascular patients; (ii) to deepen knowledge of clinical, pathophysiological, and prognostic characteristics of Fabry-related stroke.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ataque Isquémico Transitorio / Accidente Cerebrovascular Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Adult / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Neurol Sci Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ataque Isquémico Transitorio / Accidente Cerebrovascular Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Adult / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Neurol Sci Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Italia